Lords Chloro Alkali (500284) Q1 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 26/27 earnings summary
27 Jul, 2026Executive summary
Achieved highest-ever quarterly Total Income, EBITDA, and Profit After Tax in Q1 FY27, driven by improved caustic soda realizations, steady demand, and operational efficiencies.
Approved unaudited financial results for the quarter ended June 30, 2026, showing strong revenue and profit growth year-over-year.
Transitioning into a green chemical company with significant investments in renewable energy and downstream integration.
Strong management team with deep industry experience and a focus on sustainability and growth.
Board approved remuneration for key directors, subject to AGM approval.
Financial highlights
Q1 FY27 Total Income: ₹106.56 crore, up 6.07% year-over-year; EBITDA: ₹22.83 crore, up 10.38% YoY; PAT: ₹14.96 crore, up 43.16% YoY.
FY26 Total Income: ₹393.10 crore, up 44.62% YoY; EBITDA: ₹66.38 crore, up 159.24% YoY; PAT: ₹28.49 crore, up 360.90% YoY.
Basic EPS for Q1 FY27: ₹5.22 (up 25.78% YoY); FY26: ₹9.94 (up 304.07% YoY).
Net profit for Q1 FY27 was ₹14.95 crore, a significant increase from ₹8.67 crore in Q1 FY26.
EBITDA margin improved to 21.42% in Q1 FY27 and 16.89% for FY26.
Outlook and guidance
Optimistic demand outlook for the chloro-alkali industry, supported by healthy industrial activity and favorable market dynamics.
Continued focus on operational excellence, timely execution of growth initiatives, and downstream value addition.
Board's Report, Corporate Governance Report, and Management Discussion & Analysis for FY26 were approved, indicating ongoing focus on governance and strategic direction.
Latest events from Lords Chloro Alkali
- Strong FY 2026 revenue and profit growth, with margins lifted by renewables and expansion plans.500284
Q4 25/261 Jun 2026 - Q3 profit reached Rs. 356.96 lakh, with equity capital boosted by Rs. 42.7 crore from warrant conversion.500284
Q3 25/269 Feb 2026 - Turnaround year with 22% revenue growth, new capacity, and strong profit recovery.500284
Q4 24/2519 Jan 2026 - Q1 FY25 revenue grew 22.1% YoY, with strong EBITDA and PAT gains on higher volumes.500284
Q1 24/2527 Nov 2025 - H1 FY26 saw strong growth and margins, with major capex to boost scale and renewables.500284
Q2 25/2611 Nov 2025